Key result
Metabolically coupled protein modifications drive diabetic cardiomyopathy pathogenesis under hyperglycemia and insulin resistance.
Why the study?
Metabolic abnormalities in diabetic cardiomyopathy disrupt intracellular metabolite abundance and induce post-translational protein modifications, motivating a synthesis of the roles and evidence levels of metabolically coupled protein modifications in this disorder.
Answers are grounded in this paper and cite their sources.
This narrative review summarizes the roles of metabolically coupled protein modifications and metabolism-related post-translational modifications in the pathogenesis of diabetic cardiomyopathy.
Diabetic cardiomyopathy (DCM) is a diabetes‐specific myocardial disorder, characterized by structural and functional abnormalities of the heart independent of coronary artery disease, hypertension, or valvular pathology. Metabolic abnormalities are now understood to play pivotal roles in DCM pathogenesis. Chronic hyperglycemia and insulin resistance disrupt cardiac energy metabolism, shifting myocardial substrate utilization from glucose to fatty acids. These metabolic disorders lead to imbalances in intracellular metabolite abundance, which, in turn, induce abnormalities in various biochemical reactions involving these metabolites, including post‐translational modifications (PTMs) of proteins. The strong correlation between metabolism and protein PTMs has led to the concept of metabolically coupled protein modifications (MCPMs). In this narrative review, we define strict MCPMs as PTMs that directly use metabolites as substrates, and we also discuss metabolism‐related PTMs such as phosphorylation and ROS/RNS‐mediated modifications. We summarize reported roles of MCPMs in DCM, distinguish evidence levels, and outline major issues for future research.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2026) conducted a review in Diabetic cardiomyopathy. Metabolically coupled protein modifications (MCPMs) was evaluated. Metabolically coupled protein modifications driven by hyperglycemia and insulin resistance contribute to the pathogenesis of diabetic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: